Compound Detail
CHEMBL232349
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL232349 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | NUKBQTLXNISBTR-GHXNOFRVSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
4
Publications
0
Known Names
Molecular Properties
240.3
MW (Da)
2.52
ALogP
2
HBA
2
HBD
54.1
PSA (Ų)
0.79
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 6.24
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| 3-phosphoinositide-dependent protein kinase 1 CHEMBL2534 | IC50 | 6.24 | 6.24 | 580.0 | 1 |
| Serine/threonine-protein kinase tousled-like 2 CHEMBL5404 | IC50 | 5.82 | 5.82 | 1500.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| 3-phosphoinositide-dependent protein kinase 1 | IC50 | = | 580.0 | nM | 6.24 | Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay | 17531483 |
| Serine/threonine-protein kinase tousled-like 2 | IC50 | = | 1500.0 | nM | 5.82 | Inhibition of human TLK2 preincubated for 20 mins followed by 33P-ATP addition a... | 38636130 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 17531483 | 10.1016/j.bmcl.2007.04.071 | 3-phosphoinositide-dependent protein kinase 1 | 1 |
| 38636130 | 10.1016/j.ejmech.2024.116357 | Serine/threonine-protein kinase tousled-like 2 | 1 |
| 38636130 | 10.1016/j.ejmech.2024.116357 | Receptor-type tyrosine-protein kinase FLT3 | 1 |
| 38636130 | 10.1016/j.ejmech.2024.116357 | NT-3 growth factor receptor | 1 |
Data from ChEMBL 36 via Core Engine